Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1994-02-14
1998-02-17
Caputa, Anthony C.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
42419711, 4242521, 424823, 4352521, 435822, 530350, 530352, 530359, A61K 3910, C12N 121
Patent
active
057189030
ABSTRACT:
The present invention is an improved vaccine against Brucella abortus which permits differentiation between vaccinated and field strain infected cattle. The vaccine can be administered in two different forms: (1) cell envelopes isolated from an O polysaccharide antigen deficient, stable transposon mutant of B. abortus or (2) an O polysaccharide antigen deficient, stable transposon mutant of B. abortus.
REFERENCES:
patent: 2787576 (1957-04-01), Kakavas
patent: 4402939 (1983-09-01), Fournier
patent: 4831126 (1989-05-01), Bundle
patent: 5006463 (1991-04-01), Cherwonagrowdzky
patent: 5023174 (1991-06-01), Mayfield
Edwards et al., "A Study of the Immunological Properties and Infectivity of Brucella abortus Strain 45/20, McEwen, in Cattle," Vet. Rec. 57:259-265 (1945).
McEwen, A., "Further Experiments on the Infectivity of Vaccine Prepared From Brucella abortus Strain 45(20) for Cattle," Vet. Rec. 58:3-6 (1946).
Ficht et al, "Cloning the Genes Encoding the Major Outer Membrane Protein Omp III of Brucella abortus vaccine and virulent strains", DNA, 5 : 92, 1986.
Lutkenhaus, "Role of a Major Outer Membrane Protein in Escherichia coli", J. of Bact., 2: 631-637, 1977.
Sowa et al, "Physiology of F-Pilin Synthesis and Utilization", J. of Bact., 153:962-968, 1983.
O'Farrell, "High Resolution Two-Dimensional Electrophoresis of Proteins", J. of Bio. Chem., 250: 4007-4021, 1975.
Hunkapiller et al, "Isolation of Microgram Quantities of Proteins from Polyacrylamide Gels for Amino Acid Sequence Analysis", Meth. in Enz., 91: 227-236, 1983.
Alton et al, "Laboratory Techniques in Bruccellosis", World Health Org. Monograph Series (2d Ed.), 55: 11-63, 1975.
Young et al, "Construction of Genomic Libraries in Bacteriophage Vectors", Const. of Gen. Lib., 270: 270-294, (no year listed).
Young et al, "Efficient Isolation of Genes by Using Antibody Probes", Proc. Natl. Acad. Sci. USA, 80: 1194-1198, 1983.
Smith, "Recovery of DNA from Gels", Meth. in Enz., 65: 371-380, 1980.
Young et al, "Yeast RNA Polymerase II Genes: Isolation with Antibody Proves", Science, 222: 778-782, (no year listed).
Schuurs et al, "Enzyme-Immunoassay", Clinica Chimica Acta, 81: 1-40, 1977.
Towbin et al, "Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications", Proc. Natl. Acad. Sci. USA, 76: 4350-4354, 1979.
Craven et al, "Purification, Composition, and Molecular Weight of the B-Galactosidase of Escherichia coli K12", J. of Biol. Chem., 240:2468-2477, 1965.
Alton et al, "Laboratory Techniques in Brucellosis", World Health Org., Monograph series, (2d Ed.), 64-66, 1975.
Southern, "Detection of Specific Sequences Among DNA Fragments Separated by Gel Electrophoresis", J. Mol. Biol., 98:503-517, 1975.
Mackett et al, "General Method for Production and Selection of Infectious Vaccinia Virus Recombinants Expressing Foreign Genes", J. of Virol., 49: 857-864, 1984.
Hopp et al, "Prediction of protein antigenic determinants from amino acid sequences", Proc. Natl. Acad. Sci. USA, 78: 3824-3828, 1981.
Kyte et al, "A Simple Method for Displaying the Hydropathic Character of a Protein", J. Mol. Biol., 157: 105-132, 1982.
Chou et al, "Prediction of the Secondary Structure of Proteins from their Amino Acid Sequence", Advances in Enzymology, 47: 45-148, 1978.
Merrifield, "Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide", J. Amer. Chem. Soc., 85: 2149-2154, 1963.
Maniatis et al, "Construction of Genomic Libraries, Molecular Cloning", A Laboratory Manual, 270-294, 1982.
Bosseray, "Immunity to Brucella in mice vaccinated with a fraction (F8) or a killed vaccine (H38) with or without adjuvant level and duration of immunity in relation to dose of vaccine, recall injection and age of mice", Br. J. Exp. Path., 59: 354-365, 1978.
Bosseray et al, "Antagonism between two immunogens extracted from Brucella (cell wall peptidoglycan and lipopolysaccharide fractions) and inactivity of the brucellin allergen in immunization of the mouse", Ann. Microbiol., (Inst. Pasteus), 131A: 157-169, 1980.
Baldwin et al, "Immune response of cattle to Brucella abortus outer membrane proteins measured by Lymphocyte", Veterinary Immunology and Immunopathology, 9: 383-396, 1985.
Adams et al, "Analysis of Brucella abortus Antigens by Use of Monoclonal Antibodies, Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis (SDS-PAGE), and Two-Dimensional Gel Electrophoresis, Repro. and Teratology", Amr. College of Vet. Path. (thirty-sixth annual meeting) & Amer. Soc. for Vet. Clinical Path. (third annual meeting) Dec. 9-13, 1985.
Winter et al, "Immune Response to Porin in Cattle Immunized with Whole Cell, Outer Membrane, and Outer Membrane Protein Antigens of Brucella abortus Combined with Trehalose Dimycolate and Muramyl Dipeptide Adjuvants", Infection and Immunity, 42: 1159-1167, 1983.
Cunningham et al, "The Use of Killed 45/20 Adjuvant Vaccine as a Diagnostic Agent in the Final Stages of the Eradication of Brucellosis: The Clearance of Brucellosis from Problem Herds by Interpretation of Anamnestic Serological Responses", Vet. Rec., 89: 680-686, 1971.
Cunningham et al, "Vaccination of Cattle with Killed 45/20 Adjuvant Vaccine, Effects on Serological and Milk Ring Tests when used in cattle Previously Exposed to Infection or Vaccinated with S.19", Vet. Rec., 86: 2-7, 1970.
Diaz et al, "The Immuno-diffusion Method for the Identification of Cattle Vaccinated with Brucella abortus Strain 45/20", Vet. Rec., 93: 300-302, 1973.
Hall et al, "Infection and Serological Responses in Cattle given 45/20 Vaccine and Later Challenged with Brucella abortus", Australian Vet. J., 52: 409-413, 1976.
Miller et al, "A complement fixation method for quantitative differentiation of reactions to 45/20 vaccine and brucella infection", Vet. Rec., 98: 210-215, 1976.
Sutherland et al, "The Effect of Challenge with Virulent Brucella abortus on Beef Cattle Vaccinated as Calves or Adults with Either Brucella abortus Strain 19 or 45/20", Australian Vet. J., 57: 470-473, 1981.
Waghela, "Serological response to cattle, sheep and goats in Kenya vaccinated with killed Brucella melitensis strain H38 adjuvant vaccine", Vet. Rec., 112: 476-479, 1983.
Smith and Heffron, "Transposon Tn5 Mutagenesis of Brucella abortus", Infection and Immunity, 55: 2774-2776, 1987.
Harmon et al, "Survival of rough and smooth strains of Brucella abortus in bovine mammary gland macrophages", Am. J. Vet. Res., 49: 1092-1097, 1988.
Feinberg and Volgelstein, "A technique of radiolabeling DNA Restriction Endonuclease fragments to high specific activity", Analytical Biochemistry, 132: 6-13, 1983.
Smith et al, "Measurement of Protein Using Bicinchoninic Acid", Analytical Biochemistry, 150: 76-85, 1985.
Kleckner, "Transposable elements in prokaryotes", Ann. Rev. Genet., 15: 341-404.
Sowa et al, "Size, charge and structural heterogeneity of Brucella abortus lipopolysaccharides demonstrated by two-dimensional gel electrophoresis", Electrophoresis, 7: 283-288, 1986.
Plava and Makela, "Lipopolysaccharide heterogeneity in Salmonella typhimurium analyzed by sodium dodecyul sulfate-polyacrylamide gel electrophoresis", Eur. J. Biochem., 107: 137-143, 1980.
Moreno et al, "Immunochemical characterization of Brucella lipopolysaccharides and polysaccharides", Infect. Immun., 31:214-222, 1981.
Montaraz et al, "Protection against Brucella abortus in Mice with O-polysaccharide-specific monoclonal antibodies", Infect. Immun., 51: 961-963, 1986.
Moreno et al, "Characterization of a native polysaccharide hapten from Brucella melitensis", Infect. Immun., 55: 2850-2853, 1987.
Bundle et al, "Characterization of brucella polysaccharide B.", Infect. Immun., 56: 1101-1106, 1988.
Price et al, "Ability of mononuclear phagocytes from cattle naturally resistant or susceptible to brucellosis to control in vitro intracellular survival of Brucella abortus", Infect. Immun., 58: 879-886, 1990.
Moreno et al, "Purification and characterization of smooth and rough lipopolysaccharides from Brucella abortus", J. Bacteriol., 138: 361-369, 1979.
McEwen and Roberts, "Bovine Contagious Abortion, the Use of Guin
Adams Leslie Garry
Crawford Richard P.
Davis Donald S.
Ficht Thomas A.
Smith, III Roger
Caputa Anthony C.
The Texas A&M University System
LandOfFree
Vaccine comprising Brucella abortus which has O polysaccharide a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vaccine comprising Brucella abortus which has O polysaccharide a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine comprising Brucella abortus which has O polysaccharide a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1782331